Kimberly Westrich, M.A., chief strategy officer of National Pharmaceutical Council, shares her prediction for 2025.
Kimberly Westrich, M.A.
Advertisement
Articles by Kimberly Westrich, M.A.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
Understanding Hemophilia A and B
2
Nonfactor Therapies for Hemophilia: Current Evidence, Clinical Relevance and Cost Considerations
3
Nonfactor agents for hemophilia prophylaxis: A Q&A with Steven Pipe, M.D.
4
Payers Are Bracing for the Specialty Trend of the Future | AMCP Nexus 2025
5
